FIRM FIXED PRICENO SET ASIDE USED.
THE GENERAL HOSPITAL CORPORATION - ENHANCE FDA SOURCE MODEL BY INCORPORATING AND ANALYZING STATE AND REGIONAL-LEVEL DATA BAA- FY24C3DP4
PIID: 75F40124C00128Solicitation ID: FDABAA-24-00123
Signed Date: Feb 4, 2026Effective Date: Sep 25, 2024End Date: Closed on Apr 4, 2025
Key Details
Description
ENHANCE FDA SOURCE MODEL BY INCORPORATING AND ANALYZING STATE AND REGIONAL-LEVEL DATA BAA- FY24C3DP4
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.